argus

Bliss GVS Pharma Limited

NSE: BLISSGVSINE416D01022₹6,481 Cr

Timeline

Time (IST)TypeMEventSrc
06 Nov, 08:59 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mr Gagan Harsh Sharma as Managing Director of the company w.e.f. November 06, 2025.nse
06 Nov, 08:54 pm—…Bliss GVS Pharma Ltd - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Yearly Ended September 30, 2025bse
06 Nov, 08:52 pm—…Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
06 Nov, 08:45 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on November 06, 2025.nse
06 Nov, 08:44 pm—…Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, November 06, 2025bse
05 Nov, 04:47 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 33670 securities pursuant to ESOP/ESPS at its meeting held on November 05, 2025nse
29 Oct, 03:50 pm—…Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025.bse
10 Oct, 06:30 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 39450 securities pursuant to ESOP/ESPS at its meeting held on October 10, 2025nse
07 Oct, 11:15 am—…Bliss GVS Pharma Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
06 Oct, 07:50 pm—…Bliss GVS Pharma Ltd - 506197 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
30 Sept, 06:56 pm—…Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Sept, 06:52 pm—…Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, September 30, 2025bse
30 Sept, 06:46 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Narsimha Shibroor Kamath as Chief Executive Officer of the company w.e.f. September 30, 2025.nse
30 Sept, 06:44 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on September 30, 2025.nse
15 Sept, 05:23 pm—…Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 39950 securities pursuant to ESOP/ESPS at its meeting held on September 15, 2025nse
03 Sept, 07:06 pm—…Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
03 Sept, 07:03 pm—…Bliss GVS Pharma Limited has informed the Exchange about Credit Ratingnse